Corporate Finance

BingX aims to democratize crypto trading with a new partner, but our investigation reveals Trade4Me is unregulated and flagged for potential fraud.

CityHealth's 2025 report shows local policy is potent medicine. Discover how cities like Chicago are using data to tackle health, from housing to greenspace.

Imviva Biotech's 'off-the-shelf' cell therapies could make life-saving treatments faster and more accessible. But what does this mean for patients?

GoldMining Inc. renews its flexible financing tool to tap the market. We analyze the strategy, the projects at stake, and the dilution dilemma for investors.

Suburban Propane is refinancing its debt, extending it to 2035. Is this a savvy move to fund its green energy transition or a costly bet on stability?

FDA clears Phase IIb trial for CS1, an epigenetic drug aiming to reverse PAH damage, not just manage symptoms, signaling a major market and patient shift.

A massive donation provides millions of meals, revealing how food networks are the unseen infrastructure essential for a truly connected and resilient future.

Protara Therapeutics secured a $75M offering to advance its promising cancer drug, TARA-002, signaling renewed investor confidence in biotech innovation.

A food-tech firm's pivot from quiet operator to public force reveals a savvy digital strategy, a key US acquisition, and a plan to dominate the 'better-for-you' market.

A cub’s rescue reveals more than a conservation win; it showcases China's massive investment in 'ecological civilization' as a core economic strategy.

A new Canada-Germany digital alliance promises AI and quantum breakthroughs. But can this pact move from policy to patients and transform Canadian health?

A new point-of-care PCR test is moving closer to reality in India, promising to revolutionize the fight against tuberculosis and cervical cancer.

A new partnership between Logicbroker and PayPal is making AI-driven shopping a reality for merchants, building the essential infrastructure for agentic commerce.

A breakthrough therapy using the gut microbiome shows a 54% survival rate for a fatal transplant complication, heralding a new era in oncology treatment.

Procyon Partners' largest acquisition yet pushes it to nearly $9B in assets, revealing a calculated strategy for national scale in a hot M&A market.

Beyond global distribution, a tech giant is investing in its hometown, merging holiday charity with a strategic commitment to cultivating future engineers.

A strategic investment in cybersecurity firm ShorePoint reveals how private capital is becoming a critical force multiplier in securing federal agencies.

Nova Era Labs promises to revolutionize AI education with virtual labs. But in a market of giants, can it deliver on its bold claims of workforce readiness?

Pet Supplies Plus & Wag N' Wash break free with innovative financing. Here’s how autonomy and smart capital will reshape the competitive pet care market.

A key regulatory filing reveals First Trust Advisors' major stake in NCC Group, fueling speculation as the UK cybersecurity firm weighs a potential sale.